Yiping Zhang

Author PubWeight™ 0.75^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Patients with ROS1 rearrangement-positive non-small-cell lung cancer benefit from pemetrexed-based chemotherapy.	Cancer Med	2016	0.75